{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:09:44Z","timestamp":1785413384484,"version":"3.56.0"},"reference-count":93,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Matrubials Inc.","award":["22-612A"],"award-info":[{"award-number":["22-612A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Sexually transmitted infections (STIs) remain a major global health concern, with over one million new curable cases reported daily and limited long-term treatment options. Additionally, there are limited treatment options for women with bacterial vaginosis (BV), a dysbiotic condition predisposing them to STIs. Computationally designed human-milk-inspired antimicrobial peptides (AMPs) are promising candidates for novel antiviral and antibacterial therapies. This study evaluated the cervicovaginal mucosal safety and antiviral activity of three human-milk-inspired AMPs (MAT-006, UCD-MAT-001, and UCD-MAT-002) previously shown to exhibit antimicrobial activity against BV-causing pathogens. Methods: AMP cytotoxicity and inflammatory responses were assessed in relevant genital tract cell lines and cervicovaginal tissues in vitro. AMP anti-HIV-1 and anti-HSV-2 activities were characterized in female genital tract cell lines, TZM-bl cells and HEC-1-A cells, respectively, and in time-of-addition (pre-, co-, and post-HIV-1 challenge; and post-HSV-2 challenge) experiments. The impact of seminal plasma on AMPs\u2019 activity was also evaluated. Results: At the concentrations tested, all three AMPs showed minimal cytotoxicity and no pro-inflammatory responses in cellular and ectocervical tissue explant models. In both co- and post-exposure models, all three AMPs inhibited HIV-1 and HSV-2 replication with IC50 values ranging from 0.78 to 7.72 mg\/mL. MAT-006 further showed pre-exposure anti-HIV-1 activity after 6 h (IC50 = 1.07 \u00b1 0.515 mg\/mL) and 24 h (IC50 = 0.69 \u00b1 0.152 mg\/mL) of incubation. Seminal plasma did not significantly impair MAT-006 and UCD-MAT-001 antiviral activity under experimental conditions. Conclusions: These findings demonstrate the antiviral activity of human-milk-inspired AMPs against HIV-1 and HSV-2 at concentrations that are safe to the cervicovaginal mucosa in vitro, warranting further preclinical evaluation as microbicide candidates with dual antibacterial and antiviral properties.<\/jats:p>","DOI":"10.3390\/pharmaceutics18080938","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:38:54Z","timestamp":1785411534000},"page":"938","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiviral Activity and Mucosal Safety of Novel Human-Milk-Inspired Antimicrobial Peptides"],"prefix":"10.3390","volume":"18","author":[{"given":"Nazita","family":"Yousefieh","sequence":"first","affiliation":[{"name":"CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9374-6248","authenticated-orcid":false,"given":"Louise A.","family":"Ouattara","sequence":"additional","affiliation":[{"name":"CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoona","family":"Bhutta","sequence":"additional","affiliation":[{"name":"CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita M.","family":"Shah","sequence":"additional","affiliation":[{"name":"Foods for Health Institute, Department of Food Science and Technology, University of California Davis, Davis, CA 95616, USA"},{"name":"Matrubials Inc., 630 Pena Drive, Suite 100, Davis, CA 95618, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Herrera","sequence":"additional","affiliation":[{"name":"CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9641-1325","authenticated-orcid":false,"given":"Gustavo F.","family":"Doncel","sequence":"additional","affiliation":[{"name":"CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"ref_1","unstructured":"UNAIDS (2025). AIDS, Crisis and the Power to Transform: UNAIDS Global AIDS Update 2025, Joint United Nations Programme on HIV\/AIDS."},{"key":"ref_2","first-page":"508","article-title":"CROI 2025: Global epidemiology and prevention of HIV and other sexually transmitted diseases","volume":"33","author":"Buchbinder","year":"2025","journal-title":"Top. Antivir. Med."},{"key":"ref_3","unstructured":"WHO (2026, July 09). Herpes Simplex Virus. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/herpes-simplex-virus#:~:text=Most%20HSV%2D1%20infections%20are,years%20worldwide%20(2020%20data)."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: Mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex. Transm. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","article-title":"High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis","volume":"46","author":"Peebles","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bradshaw, C.S., and Brotman, R.M. (2015). Making inroads into improving treatment of bacterial vaginosis\u2014Striving for long-term cure. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1027-4"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","article-title":"Adherent biofilms in bacterial vaginosis","volume":"106","author":"Swidsinski","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.12688\/f1000research.17108.1","article-title":"Strong association between higher-risk sex and HIV prevalence at the regional level: An ecological study of 27 sub-Saharan African countries","volume":"7","author":"Kenyon","year":"2018","journal-title":"F1000Research"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajog.2019.05.016","article-title":"Bacterial vaginosis and the risk of human papillomavirus and cervical cancer","volume":"221","author":"Coudray","year":"2019","journal-title":"AM. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Govender, V., Naidoo, M., and Moodley, D. (2024). Sexually transmitted infections and bacterial vaginosis among adolescent girls and young women in the early postpartum period: A cross-sectional study. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09781-4"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/sextrans-2020-054740","article-title":"Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women","volume":"97","author":"Garrett","year":"2021","journal-title":"Sex. Transm. Infect."},{"key":"ref_13","unstructured":"CDC (2026, July 09). Sexually Transmitted Infections Treatment Guidelines, Bacterial Vaginosis, Available online: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/default.htm."},{"key":"ref_14","unstructured":"FDA (2026, July 09). Drugs@FDA: FDA-Approved Drugs, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1089\/jwh.2018.7383","article-title":"Characterization and treatment of recurrent bacterial vaginosis","volume":"28","author":"Faught","year":"2019","journal-title":"J. Women\u2019s Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/jaoac\/91.5.1116","article-title":"Development of a selective and sensitive spectrophotometric method for the trace determination of thallium(III) using 3-methyl-2-benzothiazolinone hydrazone hydrochloride and N-(1-naphthyl)-ethylenediamine dihydrochloride","volume":"91","author":"Nagaraja","year":"2008","journal-title":"J. AOAC Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","article-title":"Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin","volume":"47","author":"Petrina","year":"2017","journal-title":"Anaerobe"},{"key":"ref_18","first-page":"000226","article-title":"Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis","volume":"3","author":"Coudray","year":"2021","journal-title":"Access Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e00262-18","DOI":"10.1128\/mSphereDirect.00262-18","article-title":"Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis","volume":"3","author":"Deng","year":"2018","journal-title":"mSphere"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Muzny, C.A., and Sobel, J.D. (2022). The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment. Antibiotics, 11.","DOI":"10.20944\/preprints202203.0042.v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref_22","first-page":"114375","article-title":"Characterization of human immunodeficiency virus drug-resistance mutations among individuals with low-level-viremia in low-income and middle-income countries: A meta-analysis","volume":"15","author":"Chenya","year":"2026","journal-title":"World J. Virol."},{"key":"ref_23","unstructured":"WHO (2026, July 09). Over 1 in 5 Adults Worldwide Has a Genital Herpes Infection. Available online: https:\/\/www.who.int\/news\/item\/11-12-2024-over-1-in-5-adults-worldwide-has-a-genital-herpes-infection-who."},{"key":"ref_24","first-page":"61","article-title":"Developments in genital herpes: Progress in prevention and treatment","volume":"39","author":"Herold","year":"2026","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.cmi.2025.04.046","article-title":"Herpes simplex virus and drug resistance\u2014Comprehensive update on resistance mutations and implications for clinical management: A narrative review","volume":"31","author":"Dahne","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-3542(02)00214-0","article-title":"Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir","volume":"58","author":"Andersen","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gambacorta, N., Caputo, L., Quintieri, L., Monaci, L., Ciriaco, F., and Nicolotti, O. (2022). Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051067"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1038\/s41598-020-71404-0","article-title":"Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide","volume":"10","author":"Gomara","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acs.bioconjchem.1c00292","article-title":"Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity","volume":"32","author":"Gomara","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbagen.2016.02.008","article-title":"Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor","volume":"1860","author":"Gomara","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1128\/AAC.06108-11","article-title":"Preclinical evaluation of the HIV-1 fusion inhibitor L\u2019644 as a potential candidate microbicide","volume":"56","author":"Harman","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Pu, J., Wang, Q., Xu, W., Lu, L., and Jiang, S. (2019). Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41. Viruses, 11.","DOI":"10.3390\/v11080705"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1073\/pnas.0802666105","article-title":"Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249","volume":"105","author":"Veazey","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/aid.1993.9.1051","article-title":"A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion","volume":"9","author":"Wild","year":"1993","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100954","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12602-022-10004-y","article-title":"Milk-derived antimicrobial peptides: Overview, applications, and future perspectives","volume":"15","author":"Singh","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/IAI.00524-06","article-title":"Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis","volume":"74","author":"Valore","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/acs.jproteome.8b00604","article-title":"Peptidomics Analysis of Milk Protein-Derived Peptides Released over Time in the Preterm Infant Stomach","volume":"18","author":"Beverly","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10408690290825538","article-title":"Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing","volume":"42","author":"Gobbetti","year":"2002","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.foodchem.2017.04.056","article-title":"Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization","volume":"232","author":"Nielsen","year":"2017","journal-title":"Food Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bruni, N., Capucchio, M.T., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., and Dosio, F. (2016). Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine. Molecules, 21.","DOI":"10.3390\/molecules21060752"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109374","DOI":"10.1016\/j.foodcont.2022.109374","article-title":"A novel milk-derived peptide effectively inhibits Staphylococcus aureus: Interferes with cell wall synthesis, peptidoglycan biosynthesis disruption reaction mechanism, and its application in real milk system","volume":"144","author":"Shi","year":"2023","journal-title":"Food Control"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13594-013-0153-2","article-title":"MilkAMP: A comprehensive database of antimicrobial peptides of dairy origin","volume":"94","author":"Fliss","year":"2014","journal-title":"Dairy Sci. Technol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Shah, I.M., Lebrilla, C.B., German, J.B., and Mills, D.A. (2026). Selective Human-Milk-Inspired Antimicrobial Peptides for the Treatment of Bacterial Vaginosis. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18030371"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AAC.00392-16","article-title":"In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa","volume":"60","author":"Villegas","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2043-9113-2-5","article-title":"Monte Carlo simulation of the Spearman-Kaerber TCID50","volume":"2","author":"Wulff","year":"2012","journal-title":"J. Clin. Bioinforma"},{"key":"ref_49","first-page":"14E.1.1","article-title":"Herpes simplex virus: Propagation, quantification, and storage","volume":"00","author":"Blaho","year":"2005","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Agarwal, H.K., Chhikara, B.S., Ye, G., Bhavaraju, S., Dixit, A., Kumar, A., Doncel, G.F., and Parang, K. (2022). Synthesis and Biological Evaluation of 5\u2032-O-Fatty Acyl Ester Derivatives of 3\u2032-Fluoro-2\u2032,3\u2032-dideoxythymidine as Potential Anti-HIV Microbicides. Molecules, 27.","DOI":"10.3390\/molecules27103352"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/AAC.01129-06","article-title":"Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture","volume":"51","author":"Cummins","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zalenskaya, I.A., Joseph, T., Bavarva, J., Yousefieh, N., Jackson, S.S., Fashemi, T., Yamamoto, H.S., Settlage, R., Fichorova, R.N., and Doncel, G.F. (2015). Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128557"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachectin\/TNF--a primary mediator of the host response","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10408369009105897","article-title":"Interleukins and tumor necrosis factor in inflammation","volume":"28","author":"Warren","year":"1990","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.biocel.2009.10.009","article-title":"The role of toll-like receptors in chronic inflammation","volume":"42","author":"Drexler","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5582\/bst.2017.01103","article-title":"APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis","volume":"11","author":"Chen","year":"2017","journal-title":"Biosci. Trends"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1093\/rheumatology\/kead268","article-title":"CCL20 inhibition for treating inflammation in ankylosing spondylitis","volume":"62","author":"Won","year":"2023","journal-title":"Rheumatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ejendo\/lvae018","article-title":"Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis, and cell differentiation","volume":"190","author":"Pellitero","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.62.14.14","article-title":"C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis","volume":"62","author":"Mursalin","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: A Masterplayer in the Cytokine Network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Mugo, N.R., Mudhune, V., Heffron, R., Thomas, K.K., McLellan-Lemal, E., Njoroge, B., Peacock, S., O\u2019Connor, S.M., Nyagol, B., and Ouma, E. (2023). Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya. Front. Reprod. Health, 5.","DOI":"10.3389\/frph.2023.1118030"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2011.08.015","article-title":"Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication","volume":"10","author":"Andrei","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Thurman, A.R., Ouattara, L.A., Yousefieh, N., Anderson, P.L., Bushman, L.R., Fang, X., Hanif, H., Clark, M., Singh, O., and Doncel, G.F. (2023). A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1130101"},{"key":"ref_65","unstructured":"NLM (2026, July 16). Metronidazole\u2014Metronidazole Gel, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=526c226a-099b-4eb3-943d-c88b2763b2c1."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1095\/biolreprod.104.029603","article-title":"Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives","volume":"71","author":"Fichorova","year":"2004","journal-title":"Biol. Reprod."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/322047","article-title":"The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission","volume":"184","author":"Fichorova","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/aid.2012.0345","article-title":"Toward early safety alert endpoints: Exploring biomarkers suggestive of microbicide failure","volume":"29","author":"Mauck","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1574-695X.2006.00132.x","article-title":"Antimicrobial peptides and proteins, exercise and innate mucosal immunity","volume":"48","author":"West","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"106106","DOI":"10.1016\/j.fbio.2025.106106","article-title":"Impact of folate bio-enriched fermented beverage on vitamin D receptor and folate transporters expression in the colon: Insights from in vitro and in vivo studies","volume":"65","author":"Cucick","year":"2025","journal-title":"Food Biosci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Herrera, C., McRaven, M.D., Laing, K.G., Dennis, J., Hope, T.J., and Shattock, R.J. (2021). Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs. Vaccines, 9.","DOI":"10.3390\/vaccines9030231"},{"key":"ref_72","first-page":"1","article-title":"Candidate microbicides and their mechanisms of action","volume":"383","author":"Herrera","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0897.2010.00931.x","article-title":"Role of semen in HIV-1 transmission: Inhibitor or facilitator?","volume":"65","author":"Doncel","year":"2011","journal-title":"AM. J. Reprod. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/522606","article-title":"Seminal plasma reduces the effectiveness of topical polyanionic microbicides","volume":"196","author":"Patel","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Neurath, A.R., Strick, N., and Li, Y.Y. (2006). Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infect. Dis., 6.","DOI":"10.1186\/1471-2334-6-150"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/humrep\/dei496","article-title":"Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: Involvement in the sexual transmission of HIV","volume":"21","author":"Berlier","year":"2006","journal-title":"Hum. Reprod."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2007.10.014","article-title":"Semen-derived amyloid fibrils drastically enhance HIV infection","volume":"131","author":"Munch","year":"2007","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1074\/jbc.M111.314336","article-title":"Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248\u2013286) peptide","volume":"287","author":"Olsen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/molehr\/gam028","article-title":"Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells","volume":"13","author":"Sharkey","year":"2007","journal-title":"Mol. Hum. Reprod."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0119023","DOI":"10.1128\/jvi.01190-23","article-title":"Semen enhances transmitted\/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies","volume":"98","author":"Wettstein","year":"2024","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3390\/v7042057","article-title":"Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection","volume":"7","author":"Torres","year":"2015","journal-title":"Viruses"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"Bailer","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). Candidate anti-herpesviral drugs; mechanisms of action and resistance. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press.","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cmdc.201000289","article-title":"Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41","volume":"5","author":"Cai","year":"2010","journal-title":"ChemMedChem"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e70328","DOI":"10.1002\/jcc.70328","article-title":"A Review of Current Computational Tools for Peptide-Protein Docking","volume":"47","author":"Martins","year":"2026","journal-title":"J. Comput. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375","author":"Polonis","year":"2008","journal-title":"Virology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.xpro.2021.100708","article-title":"In vitro and in vivo evaluation of virus-induced innate immunity in mouse","volume":"2","author":"Shen","year":"2021","journal-title":"STAR. Protoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e012717","DOI":"10.1136\/bmjgh-2023-012717","article-title":"Twenty years of herpes simplex virus type 2 (HSV-2) research in low-income and middle-income countries: Systematic evaluation of progress made in addressing WHO prioritiesfor research in HSV-2 epidemiology and diagnostics","volume":"9","author":"Jama","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"ofaf446","DOI":"10.1093\/ofid\/ofaf446","article-title":"HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024","volume":"12","author":"Kagan","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","unstructured":"WHO (2025). Global Antibiotic Resistance Surveillance Report 2025: WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS), WHO."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Abbe, C., and Mitchell, C.M. (2023). Bacterial vaginosis: A review of approaches to treatment and prevention. Front. Reprod. Health, 5.","DOI":"10.3389\/frph.2023.1100029"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/938\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:42:07Z","timestamp":1785411727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":93,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmaceutics18080938"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18080938","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}